The relationship between FGF-23 and ghrelin levels in CKD patients: preliminary data.
Minerva urologica e nefrologica = The Italian journal of urology and nephrology, cilt.68, sa.2, ss.227-32, 2016 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 68 Sayı: 2
- Basım Tarihi: 2016
- Dergi Adı: Minerva urologica e nefrologica = The Italian journal of urology and nephrology
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.227-32
- İstanbul Üniversitesi Adresli: Evet
Özet
BACKGROUND: Fibroblast growth factor (FGF)-23 is a recently discovered phosphaturic hormone that increases in chronic kidney disease (CKD). It has been accepted as a determinant of mortality and a therapeutic target in these patients. Ghrelin is a hormone that has roles in energy and nutrient metabolism. Ghrelin level was found to be increased in CKD patients. This is a controlled study in which the relationship between FGF-23 and ghrelin levels in CKD patients has been studied.